GE HealthCare sets new standards in diagnostic imaging with SIGNA PET/MR AIR System

USA — GE HealthCare is set to make a groundbreaking debut of the SIGNA PET/MR AIR system at the prestigious Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2023 annual meeting.

This cutting-edge technology integrates GE HealthCare’s advanced AIR technologies into the SIGNA PET/MR AIR system, aiming to enhance diagnostic precision, simplify treatment evaluation, and elevate patient comfort.

The recent FDA approvals of new PET radiotracers and therapeutic approaches for diseases like prostate cancer and Alzheimer’s Disease emphasize the critical need for reliable and comprehensive imaging solutions throughout the patient care journey.

GE HealthCare’s unique AIR technologies incorporated into the SIGNA PET/MR AIR system are designed to meet the evolving demands of these patient populations.

These technologies include AIR Coils, which enhance patient comfort, AIR Recon DL, which improves MR image quality and reduces scan time, and MotionFree Brain, which mitigates motion-related PET image degradation.

Revolutionizing prostate cancer diagnosis and treatment

Prostate cancer, the second most prevalent cancer globally, has witnessed a transformative shift with the introduction of prostate-specific membrane antigen (PSMA)-targeted radiotracers for imaging diagnostics and theranostics.

The integration of PSMA-targeted PET radiotracers with GE HealthCare’s high-sensitivity PET and the anatomical precision of MRI in the SIGNA PET/MR AIR system holds immense potential for precise diagnosis, staging, and restaging of prostate cancer.

Furthermore, it can aid in selecting patients for subsequent PSMA-targeted radioligand therapy.

The SIGNA PET/MR AIR system incorporates AIR Recon DL, leveraging deep learning-based MR image reconstruction to improve image quality while significantly reducing scan time.

GE HealthCare’s AIR Coil technology, which conforms effortlessly to the human body, enhances the quality of MR imaging while ensuring patient comfort.

This advanced technology provides a thinner and lighter solution, enabling more accurate PET quantitation compared to conventional rigid RF coils.

Advancing Alzheimer’s Disease imaging

Alzheimer’s Disease affects millions of individuals globally, and GE HealthCare is at the forefront of delivering cutting-edge products and solutions to enable accurate diagnosis, effective therapy planning, and continuous monitoring of the disease.

With recent advancements in disease-modifying drugs, additional imaging using both MR and PET has become crucial.

The SIGNA PET/MR AIR system introduced by GE HealthCare features the industry’s most sensitive Time-of-Flight (ToF) PET detector in a PET/MR configuration.

This breakthrough technology empowers clinicians to achieve early diagnosis, gain valuable insights into disease progression, and detect adverse effects, all in a single scan.

By combining the anatomical precision of MRI with high-sensitivity PET, the SIGNA PET/MR AIR system revolutionizes Alzheimer’s Disease imaging.

One of the significant challenges in imaging exams is patient movement. However, GE HealthCare’s MotionFree Brain PET, integrated into the SIGNA PET/MR AIR system, manages motion without the need for external tracking devices.

This groundbreaking solution ensures consistent image quality, even in challenging patients, significantly enhancing the accuracy and efficiency of diagnosis.

Additionally, it minimizes the need for repeat scans, reducing patient discomfort and streamlining the imaging process.

Jie Xue, President, and CEO of MR at GE HealthCare expressed, “The SIGNA PET/MR AIR system continues our legacy of delivering innovative technologies that address a comprehensive range of clinical diseases.

GE notes that its latest PET/MR technology will directly impact challenging diseases like prostate cancer and Alzheimer’s Disease, which require precise and comprehensive imaging for accurate diagnosis, treatment planning, and therapy monitoring.

For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook.